Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos F Lagos

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Plos One|March 26, 2013
An amphipathic alpha-helix in the prodomain of cocaine and amphetamine regulated transcript peptide precursor serves as its sorting signal to the regulated secretory pathwayElías H Blanco, Carlos F Lagos, María Estela Andrés, et al.
Frontiers in Endocrinology|March 9, 2018
Molecular Modeling of Structures and Interaction of Human Corticotropin-Releasing Factor (CRF) Binding Protein and CRF Type-2 ReceptorPaula G Slater, Sebastian E Gutierrez-Maldonado, Katia Gysling, et al.
Frontiers in Genetics|December 13, 2024
Case Report: Concurrent <i>de novo</i> pathogenic variants in the <i>LMNA</i> gene as a cause of sporadic partial lipodystrophyJosé L Santos, José Patricio Miranda, Carlos F Lagos, et al.
Molecular Pharmaceutics|December 17, 2013
Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acidsPablo M González, Carlos F Lagos, Weslyn C Ward, et al.
Current Hypertension Reports|February 4, 2016
Aldosterone Production and Signaling Dysregulation in ObesityAndrea Vecchiola, Carlos F Lagos, Cristian A Carvajal, et al.
Frontiers in Pharmacology|July 10, 2026
Structure-based virtual screening for selective connexin hemichannel blockers: a historical perspective on the discovery of a small organic inhibitorCarlos F Lagos, Anibal Vargas, Anibal García, et al.
Molecules (Basel, Switzerland)|September 23, 2017
Novel FXa Inhibitor Identification through Integration of Ligand- and Structure-Based ApproachesCarlos F Lagos, Gerardine F Segovia, Nicolás Nuñez-Navarro, et al.
Metabolism: Clinical and Experimental|April 4, 2025
A complex multisystem disorder including hypopituitarism and hypoparathyroidism, associated with mutation in the gene encoding fatty acid synthase (FASN)L C Gregory, S Krywawych, S Rahman, et al.
Clinical Science (London, England : 1979)|July 17, 2014
Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular systemMaria Paz Ocaranza, Luis Michea, Mario Chiong, et al.
Chemical Biology & Drug Design|November 18, 2008
Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptaseCarlos F Lagos, Julio Caballero, Fernando D Gonzalez-Nilo, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Plos One|March 26, 2013
An amphipathic alpha-helix in the prodomain of cocaine and amphetamine regulated transcript peptide precursor serves as its sorting signal to the regulated secretory pathwayElías H Blanco, Carlos F Lagos, María Estela Andrés, et al.
Frontiers in Endocrinology|March 9, 2018
Molecular Modeling of Structures and Interaction of Human Corticotropin-Releasing Factor (CRF) Binding Protein and CRF Type-2 ReceptorPaula G Slater, Sebastian E Gutierrez-Maldonado, Katia Gysling, et al.
Frontiers in Genetics|December 13, 2024
Case Report: Concurrent <i>de novo</i> pathogenic variants in the <i>LMNA</i> gene as a cause of sporadic partial lipodystrophyJosé L Santos, José Patricio Miranda, Carlos F Lagos, et al.
Molecular Pharmaceutics|December 17, 2013
Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acidsPablo M González, Carlos F Lagos, Weslyn C Ward, et al.
Current Hypertension Reports|February 4, 2016
Aldosterone Production and Signaling Dysregulation in ObesityAndrea Vecchiola, Carlos F Lagos, Cristian A Carvajal, et al.
Frontiers in Pharmacology|July 10, 2026
Structure-based virtual screening for selective connexin hemichannel blockers: a historical perspective on the discovery of a small organic inhibitorCarlos F Lagos, Anibal Vargas, Anibal García, et al.
Molecules (Basel, Switzerland)|September 23, 2017
Novel FXa Inhibitor Identification through Integration of Ligand- and Structure-Based ApproachesCarlos F Lagos, Gerardine F Segovia, Nicolás Nuñez-Navarro, et al.
Metabolism: Clinical and Experimental|April 4, 2025
A complex multisystem disorder including hypopituitarism and hypoparathyroidism, associated with mutation in the gene encoding fatty acid synthase (FASN)L C Gregory, S Krywawych, S Rahman, et al.
Clinical Science (London, England : 1979)|July 17, 2014
Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular systemMaria Paz Ocaranza, Luis Michea, Mario Chiong, et al.
Chemical Biology & Drug Design|November 18, 2008
Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptaseCarlos F Lagos, Julio Caballero, Fernando D Gonzalez-Nilo, et al.
Pageof 6